66N-17903-38286
2 vaccinations
14 coded responses
20 check-ins
14 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 850 / AZ
- Registered
- 2021-06-23
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-19
Dose 1 — Pfizer-BioNTech
-
2021-06-23
Registered in v-safe
-
2021-06-23
Survey response — days 1–6 daily, dose 1MedDRA: Cognitive disorder, Dizziness — Feeling: Poor · Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Dizziness, reduced sense of smell, reduced cognitive functionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-24
Survey response — days 1–6 daily, dose 1MedDRA: Cognitive disorder, Dizziness — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Dizziness, reduced cognitive functionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-25
Survey response — days 1–6 daily, dose 1MedDRA: Balance disorder, Cognitive disorder, Dizziness — Feeling: Poor · Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Reduced cognitive function, dizziness, balance issuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-25
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-26
Survey response — day 7, dose 1MedDRA: Cognitive disorder, Dizziness — Feeling: Poor · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Dizziness, reduced cognitive function,MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-01
- 2021-07-03
- 2021-07-06
-
2021-07-10
Dose 2 — Pfizer-BioNTech
-
2021-07-10
Survey response — day 0, dose 2MedDRA: Cognitive disorder, Dizziness — Feeling: Fair · Headache, Fatigue or tirednessFree text: Dizziness, reduced cognitive functionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-07-12
Survey response — days 1–6 daily, dose 2MedDRA: Cognitive disorder — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Reduced cognitive functionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-13
Survey response — days 1–6 daily, dose 2MedDRA: Cognitive disorder, Hyposmia — Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolFree text: Reduced sense of smell, reduced cognitive functionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-14
Survey response — days 1–6 daily, dose 2MedDRA: Disturbance in attention, Dizziness, Parosmia — Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Dizziness, reduced cognitive function, reduced sense of smellMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-15
Survey response — days 1–6 daily, dose 2MedDRA: Cognitive disorder, Hyposmia — Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Reduced cognitive function, reduced sense of smellMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-16
Survey response — days 1–6 daily, dose 2MedDRA: Cognitive disorder, Hyposmia — Feeling: Fair · Site: Redness · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Reduced cognitive function, reduced sense of smellMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-17
Survey response — day 7, dose 2MedDRA: Cognitive disorder — Feeling: Fair · Site: Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Reduced cognitive functionMedDRA releases: 2024-11 · check-in free text available
-
2021-07-24
Survey response — day 14, dose 2MedDRA: Chest pain, Dyspnoea, Influenza like illness, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Flu-like symptoms: sore throat, congestion, chest pain, slight difficulty breathing.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-07-31
- 2021-08-07
-
2021-08-14
Survey response — day 35, dose 2MedDRA: Ageusia, Anosmia, Fatigue — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Increase in exhaustion and no ability to taste or smell.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-21
- 2021-10-09
-
2022-01-08
Survey response — 6 months, dose 2MedDRA: Cognitive disorder, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Still fatigued and having reduced cognitive function.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-19 | Pfizer-BioNTech | No |
| 2 | 2021-07-10 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Dizziness, reduced sense of smell, reduced cognitive function
Systemic reaction (other): Dizziness, reduced cognitive function
Systemic reaction (other): Reduced cognitive function, dizziness, balance issues
Release 9 — day 7, dose 1
Systemic reaction (other): Dizziness, reduced cognitive function,
Release 9 — day 0, dose 2
Systemic reaction (other): Dizziness, reduced cognitive function
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Reduced cognitive function
Systemic reaction (other): Reduced sense of smell, reduced cognitive function
Systemic reaction (other): Dizziness, reduced cognitive function, reduced sense of smell
Systemic reaction (other): Reduced cognitive function, reduced sense of smell
Systemic reaction (other): Reduced cognitive function, reduced sense of smell
Release 9 — day 7, dose 2
Systemic reaction (other): Reduced cognitive function
Release 9 — day 14, dose 2
Symptoms: Flu-like symptoms: sore throat, congestion, chest pain, slight difficulty breathing.
Release 9 — day 35, dose 2
Symptoms: Increase in exhaustion and no ability to taste or smell.
Release 10 — 6 months, dose 2
Symptoms: Still fatigued and having reduced cognitive function.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ✓ | · | ✓ |
| SD | Anosmia | ✓ | · | ✓ |
| SD | Chest pain | ✓ | · | ✓ |
| SD | Cognitive disorder | · | · | ✓ |
| SD | Dyspnoea | ✓ | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Influenza like illness | ✓ | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SRO | Balance disorder | ✓ | ✓ | ✓ |
| SRO | Cognitive disorder | ✓ | ✓ | ✓ |
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hyposmia | ✓ | ✓ | ✓ |
| SRO | Parosmia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release